Seung C. Sohn

Array ( [id] => 7488154 [patent_doc_number] => 20110251283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => '1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF MAST CELL MEDIATED DISEASES' [patent_app_type] => utility [patent_app_number] => 12/998962 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11634 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251283.pdf [firstpage_image] =>[orig_patent_app_number] => 12998962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7729709 [patent_doc_number] => 08101600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Method of treating depression' [patent_app_type] => utility [patent_app_number] => 12/641968 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5440 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101600.pdf [firstpage_image] =>[orig_patent_app_number] => 12641968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494969 [patent_doc_number] => 20100093783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Composition for treatment of common cold' [patent_app_type] => utility [patent_app_number] => 12/654145 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14450 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093783.pdf [firstpage_image] =>[orig_patent_app_number] => 12654145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6429916 [patent_doc_number] => 20100143269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ASTHMA' [patent_app_type] => utility [patent_app_number] => 12/633510 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7890 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143269.pdf [firstpage_image] =>[orig_patent_app_number] => 12633510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490715 [patent_doc_number] => 20110237660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'ORAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/132932 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4102 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237660.pdf [firstpage_image] =>[orig_patent_app_number] => 13132932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6604492 [patent_doc_number] => 20100063062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'NOVEL USE OF 1-[4-(5-CYANOINDOL-3-YL)BUTYL]-4-(2-CARBAMOYL-BENZOFURAN-5-YL)-PIPERAZINE AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS' [patent_app_type] => utility [patent_app_number] => 12/620049 [patent_app_country] => US [patent_app_date] => 2009-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9688 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063062.pdf [firstpage_image] =>[orig_patent_app_number] => 12620049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685354 [patent_doc_number] => 20100120787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'MODIFICATION OF AMYLOID-BETA LOAD IN NON-BRAIN TISSUE' [patent_app_type] => utility [patent_app_number] => 12/618656 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16606 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120787.pdf [firstpage_image] =>[orig_patent_app_number] => 12618656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375881 [patent_doc_number] => 08680146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Organic compounds' [patent_app_type] => utility [patent_app_number] => 13/128832 [patent_app_country] => US [patent_app_date] => 2009-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5471 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13128832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511515 [patent_doc_number] => 20110257225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'CYCLOHEXYLAMINE DERIVATIVE CONTAINING PHENYL GROUP, AND THERAPEUTIC AGENT FOR DISEASES ACCOMPANIED BY CENTRAL NERVOUS SYSTEM DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/126162 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10632 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257225.pdf [firstpage_image] =>[orig_patent_app_number] => 13126162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320503 [patent_doc_number] => 20100113380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'P2X7 ANTAGONISTS TO TREAT AFFECTIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/581525 [patent_app_country] => US [patent_app_date] => 2009-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3118 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113380.pdf [firstpage_image] =>[orig_patent_app_number] => 12581525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616769 [patent_doc_number] => 20100099735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/580464 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 36600 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099735.pdf [firstpage_image] =>[orig_patent_app_number] => 12580464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467246 [patent_doc_number] => 20100190832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and structural templates' [patent_app_type] => utility [patent_app_number] => 12/587990 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14161 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190832.pdf [firstpage_image] =>[orig_patent_app_number] => 12587990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744366 [patent_doc_number] => 20120022032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'CORTICOSTEROID COMPOSITIONS AND METHODS OF TREATMENTS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/123670 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9089 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022032.pdf [firstpage_image] =>[orig_patent_app_number] => 13123670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6355644 [patent_doc_number] => 20100022492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'THERAPEUTIC CAUSING CONTRACTION OF MUCOSAL TISSUE, METHOD OF TREATING DISEASES RELATING TO MUCOSAL TISSUES, INJECTOR AND THERAPEUTIC SET' [patent_app_type] => utility [patent_app_number] => 12/574736 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 27218 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022492.pdf [firstpage_image] =>[orig_patent_app_number] => 12574736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9345090 [patent_doc_number] => 08664237 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'Spiperone derivatives and methods of treating disorders' [patent_app_type] => utility [patent_app_number] => 13/122537 [patent_app_country] => US [patent_app_date] => 2009-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 39 [patent_no_of_words] => 16473 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13122537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307695 [patent_doc_number] => 20100069494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'LOWERING OF PROTEINS ASSOCIATED WITH ALZHEIMER\'S DISEASE BY INTERRUPTING GENE TRANSCRIPTION WITH A SMALL MOLECULE' [patent_app_type] => utility [patent_app_number] => 12/570429 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3280 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069494.pdf [firstpage_image] =>[orig_patent_app_number] => 12570429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222718 [patent_doc_number] => 20100056489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'TREATMENT OF NEUROPATHIC PAIN' [patent_app_type] => utility [patent_app_number] => 12/567421 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7385 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056489.pdf [firstpage_image] =>[orig_patent_app_number] => 12567421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9691935 [patent_doc_number] => 08822529 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Long-chain carboxychromanols and analogs for use as anti-inflammatory agents' [patent_app_type] => utility [patent_app_number] => 13/119737 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8154 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13119737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538432 [patent_doc_number] => 08314153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Treatment of pervasive developmental disorders with redox-active therapeutics' [patent_app_type] => utility [patent_app_number] => 12/555700 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16285 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12555700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4493590 [patent_doc_number] => 07956065 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-07 [patent_title] => 'Pharmaceutical compounds' [patent_app_type] => utility [patent_app_number] => 12/555695 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 13152 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/956/07956065.pdf [firstpage_image] =>[orig_patent_app_number] => 12555695 [rel_patent_id] =>[rel_patent_doc_number] =>)